课题基金 / 基金详情

A Defined Abeta Oligomer Epitope: Theranostic Applications

A Defined Abeta Oligomer Epitope: Theranostic Applications
确定的 Abeta 寡聚体表位：治疗诊断应用
批准号：
324767
负责人：
Cashman Neil R
金额：
$30.54万
依托单位：
Brain Research Centre (Vancouver, BC)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-03-01 至 2018-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=324767&lang=en
关键词：
Abeta Oligomers Active Immunization Alzheimer Disease Biomarkers Commercialization Diagnosis Knowledge Translation Oligomer-Specific Antibodies Passive Immunization Therapeutic

项目摘要

项目成果

Cashman Neil R的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Identification of methods for early diagnosis and treatment of Alzheimer's disease is a top priority for medical science. Small aggregates of the protein amyloid-beta called oligomers have been identified as being the primary toxic agent in Alzheimer's di
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathobiological mechanisms of misfolded wild-type Cu/Zn superoxide dismutase: A common pathway in amyotrophic lateral sclerosis
Misfolding of Cu/Zn superoxide dismutase by pathological FUS and TDP43: relevance to amyotrophic lateral sclerosis
A defined cyclic peptide epitope specific to Abeta oligomers: Active and passive vaccination in mouse models of Alzheimer's disease
  • 批准号：
    268560
  • 项目类别：
    Operating Grants
  • 资助金额：
    $21.86万
  • 财政年份：
    2012
  • 负责人：
    Cashman Neil R
  • 依托单位：
    University of British Columbia
CANADA RESEARCH CHAIRHOLDER - TITULAIRE DE CHAIRE DE RECHER DU CANADA
  • 批准号：
    256542
  • 项目类别：
  • 资助金额：
    $101.99万
  • 财政年份：
    2011
  • 负责人：
    Cashman Neil R
  • 依托单位：
    University of British Columbia
海外基金